Compatibility of Family History Cancer Guidelines With Meaningful Use Standards

Author:

Aziz Ayesha1,Pflieger Lance1,O’Connell Nathaniel1,Schiffman Joshua1,Welch Brandon M.1

Affiliation:

1. Ayesha Aziz, Nathaniel O’Connell, and Brandon M. Welch, Medical University of South Carolina, Charleston, SC; and Lance Pflieger and Joshua Schiffman, University of Utah, Salt Lake City, UT.

Abstract

Purpose To evaluate the potential of implementing established family cancer guidelines as clinical decision support within meaningful use (MU)–compliant health information technology systems. Methods We conducted a systematic analysis of cancer guidelines involving family health history (FHx) published before 2015. By comparing existing cancer guideline statements to current MU FHx standard requirements, we determined whether the cancer guideline statements could be implemented as clinical decision support. For guidelines that could not implemented, we determined the primary reasons for incompatibility. Results A total of 531 statements from 55 guidelines published by 11 different organizations were reviewed and analyzed. Overall, 18% to 66% of guideline statements could or could not be implemented in MU-compliant health information technology systems, depending on which MU standard was used. Health Level Seven (HL7) models performed better than SNOMED models. Implementability of guideline statements varied by cancer type and guideline organizations. The greatest deficiencies in implementability of statements were largely a result of the fact that MU standards required only first-degree relatives and that FHx terms used in guidelines statements were ambiguous. Conclusion FHx cancer guidelines and MU-based systems vary widely and are mostly incompatible. We identified sources of incompatibility and made recommendations that could improve the implementability of FHx cancer guidelines. Our findings and recommendations can enhance the use of established FHx cancer risk guidelines in routine clinical workflows.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

General Medicine

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Environmental scan of family chart linking for genetic cascade screening in a U.S. integrated health system;Frontiers in Genetics;2022-08-11

2. The use of SNOMED CT, 2013-2020: a literature review;Journal of the American Medical Informatics Association;2021-06-21

3. Surface Patterning of Silicon and Germanium using Focused Ion Beam for the Development of FinFET Structure;2019 IEEE Regional Symposium on Micro and Nanoelectronics (RSM);2019-08

4. Diagnostic Approaches Techniques in Concussion/Mild Traumatic Brain Injury;Neurosensory Disorders in Mild Traumatic Brain Injury;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3